Ionis Pharmaceuticals | IONS - Le Bénéfice D'Exploitation





Le Bénéfice D'Exploitation Changement Date
Agios Pharmaceuticals USD -110.02M 11.55M 2026-03
Alnylam Pharmaceuticals USD 112.6M 24.99M 2026-06
Arrowhead Research USD -170.09M 28.83M 2026-06
Astellas Pharma JPY 185.36B 136.79B 2026-06
BioCryst Pharmaceuticals USD 98.46M 161.92M 2026-06
BioMarin Pharmaceutical USD 105.6M 24.04M 2026-06
Celltrion KRW 12.9B 822.77M 2026-03
Cspc Pharmaceutical CNY 206.26M 1.02B 2025-12
Deva Holding AS TRY 964.87M 240.32M 2023-09
Divis Laboratories Ltd INR 11.29B 3.15B 2026-06
Exelixis USD 248.41M 2.93M 2026-06
Halozyme Therapeutics USD -63.72M 1.95M 2026-06
Ionis Pharmaceuticals USD -102.29M 15.71M 2026-06
Kangmei Pharma CNY -10.94M 15.75M 2026-03
Knight Therapeutics CAD 6.21M 3.27M 2025-12
Laboratorios Farma EUR 135.05M 49.84M 2023-12
Malin Corporation EUR -1.1M 400K 2024-12
Medical Developments International AUD -36K 444K 2025-12
Moderna USD -815M 573M 2026-06
Nektar Therapeutics USD -38.26M 19.17M 2026-03
Neuren Pharmaceuticals AUD 17.01M 11.56M 2025-12
Neurocrine Biosciences USD 219.9M 5.3M 2026-06
Novartis USD 4.75B 515M 2026-06
Omeros USD -35.41M 23.75M 2024-09
OPKO Health USD -51.02M 12.7M 2026-03
Organigram Holdings CAD -9.79M 10.33M 2026-03
Ovoca Bio EUR -173K 990K 2025-12
Pfizer USD 667M 4.32B 2026-06
Pharma Mar EUR -1.4M 2.03M 2026-06
PTC Therapeutics USD 45.89M 127.51M 2026-03
Qiagen NV USD 141.4M 24.77M 2026-06
Regeneron Pharmaceuticals USD 1.42B 675.7M 2026-06
Roche Holding CHF 11.46B 1.91B 2026-06
Sarepta Therapeutics USD 13.29M 345.14M 2026-06
Sartorius EUR 164M 3.3M 2026-06
Sino Biopharmaceutical CNY 5.18B 3.32B 2025-06
Tilray USD -20.01M 9.34M 2025-09
Ultragenyx Pharmaceutical USD -75M 141M 2026-06
Vertex Pharmaceuticals USD 1.27B 129.9M 2026-06
Zealand Pharma A/S -539M 168.05M 2026-03
Zz Pientze Pharmaceu CNY 362.83M 474.98M 2026-06